Medical Diagnostic Laboratories

What Medical Diagnostic Laboratories does

Medical Diagnostic Laboratories (MDL) is a CLIA-certified, CAP-accredited reference laboratory headquartered in Hamilton, New Jersey, founded in 1997 and operating as a privately held member of the Genesis Biotechnology Group. The company provides high-complexity molecular diagnostic testing using PCR-based technology, anchored to a set of proprietary specimen collection platforms: OneSwab® (women's health), UroSwab® (urology), NasoSwab® (respiratory), and X-Plate Technology® (Candida antifungal resistance). Each platform is engineered to enable multiple PCR assays from a single specimen, supporting simultaneous pathogen detection and resistance profiling with high sensitivity and specificity.

MDL sells testing services to physicians, hospitals, and laboratories across multiple clinical verticals, including women's health and gynecology (including BRCAcare® hereditary cancer risk assessment), urology, dermatology, microbiome analysis, vector-borne diseases (Lyme and related tick-borne pathogens), pharmacogenomics, and respiratory infections (including the CombiVid® combined SARS-CoV-2 and influenza panel). It holds clinical laboratory licenses in seven U.S. states and Medicare Provider status, and bills Medicare nationwide and Medicaid in most states. Commercial reach is built around three regional VP-led sales divisions (East, Mid-Atlantic & Southeast, Central), a physician client portal integrated with LifePoint Informatics for ordering and result retrieval, call-center-based ordering support, and clinical education channels such as The Laboratorian publication and conference participation.

MDL generates revenue primarily through fee-for-service laboratory testing reimbursed via insurance (Medicare, Medicaid, commercial), with a sales-led GTM motion targeting distributed healthcare providers rather than concentrated enterprise accounts. The business is self-funded within the Genesis Biotechnology Group, with no disclosed venture funding rounds or M&A activity, and operates as a multi-vertical specialty reference lab rather than a high-volume commodity testing operation.

Name

Medical Diagnostic Laboratories

Legal name

Medical Diagnostic Laboratories

Website

https://mdlab.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Medical Diagnostic Laboratories is a CLIA-certified, CAP-accredited reference laboratory providing PCR-based molecular diagnostic testing in women's health, urology, dermatology, microbiome, vector-borne disease, pharmacogenomics, and respiratory infections to physicians, hospitals, and laboratories across multiple U.S. states.

Ownership category

akta.pro rank

Headquarters

HQ city

Manchester Township

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: MDL generates revenue through molecular diagnostic testing services performed for physicians, laboratories, and hospitals. Testing includes PCR-based assays for infectious diseases, genetic testing, BRCA testing, and pharmacogenomics. The company offers unique, non-invasive, highly stable specimen collection platforms.
2. Insurance Billing: MDL files insurance claims for Medicare throughout the United States and Medicaid in most states. The company accepts various payment arrangements including deductibles, co-pays, and co-insurance based on patient insurance plans.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Medical Diagnostic Laboratories (MDL) is a CLIA-certified reference laboratory performing high-complexity, automated DNA-based molecular analysis using PCR technology. The laboratory provides clinically effective infectious disease, genetic, pharmacogenomic, and cancer diagnostics for healthcare providers, leveraging proprietary specimen collection and transport platforms (OneSwab®, UroSwab®, NasoSwab®) that enable multiple PCR-based tests from a single specimen with high sensitivity and specificity.

Product overview

Medical Diagnostic Laboratories (MDL) is a reference laboratory offering molecular diagnostic testing services, built around its proprietary specimen collection platforms (OneSwab®, UroSwab®, and NasoSwab®). These unique collection devices enable MDL to perform multiple PCR-based tests from single specimens with high sensitivity and specificity. MDL's portfolio includes women's health and gynecology testing (centered on the BRCAcare® brand for hereditary breast cancer risk), dermatology services, urology testing, microbiome testing, vector-borne disease testing, pharmacogenomics testing, and respiratory infectious disease testing (including the CombiVid® Panel for combined COVID-19 and influenza detection). The company operates primarily as a reference laboratory providing high-complexity, automated DNA-based molecular analysis for the detection, diagnosis, and treatment of bacterial, viral, and fungal infections as well as genetic-based testing and cancer diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

• One*Swab®: Proprietary swab specimen collection platform for women's health clinical diagnostics
• Uro*Swab®
• Naso*Swab®
• BRCAcare®
• CombiVid®
• X-Plate Technology®

Products and services

• OneSwab® Proprietary non-invasive specimen collection and transport platform that enables multiple PCR-based tests from a single swab specimen with high sensitivity and specificity, used for women's health clinical diagnostics.
• UroSwab® Highly stable urine specimen collection and transport platform that enables a variety of PCR-based tests for urology applications.
• NasoSwab® Proprietary nasopharyngeal specimen collection platform used for respiratory infectious disease testing including influenza and COVID-19.
• BRCAcare® Breast cancer high-risk genetic testing panel including BRCA1 and BRCA2 gene analysis for hereditary breast and gynecologic cancer risk assessment.
• CombiVid® Panel Combined PCR-based testing panel for simultaneous detection of SARS-CoV-2 and Influenza virus from a single specimen.
• Women's Health Testing Molecular diagnostic testing services for women's health and gynecology including infectious disease testing, genetic testing, and cancer diagnostics for women's health specialists.
• Dermatology Testing Services Molecular and genetic testing services for dermatological conditions including skin and soft tissue infections, melanoma, and other dermatological disorders.
• Urology Testing Molecular diagnostic testing for urological conditions including urinary tract infections and urogenital pathogens using proprietary UroSwab® collection platform.
• Microbiome Testing Testing services for gut bacterial microbiome analysis and vaginal microbiome assessment.
• Vector-Borne Diseases Testing Molecular diagnostic testing for tick-borne and vector-borne diseases including Lyme disease, Ehrlichia, Anaplasma, and other vector-borne pathogens.
• Pharmacogenomics Testing Genetic testing services that analyze how individuals metabolize medications to guide personalized treatment decisions.
• Coronavirus Testing PCR-based molecular testing services for SARS-CoV-2 (COVID-19) including individual and combined panel testing.

Named customers3 records

Segments7 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• Genesis Biotechnology GroupcoreOthersMDL is a member of the Genesis Biotechnology Group, a diversified healthcare company with investments in biotechnology, health, hospitality, and manufacturing. Genesis Global Group includes multiple affiliated companies including Genesis Drug Discovery & Development, Institute for Biomarker Research, 4path Ltd., and others.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• SunPath-MDL (sister lab within Genesis Biotechnology Group): Affiliated reference laboratory within MDL's parent Genesis Biotechnology Group offering complementary molecular dermatopathology and infectious disease testing; useful as a comp for sibling-lab economics and cross-sell potential.
• Meridian Bioscience (now part of Revvity / Silliker): Develops and supplies molecular diagnostic reagents and tests, including infectious disease PCR assays used by clinical laboratories — analogous layer of the diagnostics value chain where MDL operates.

Direct peers

• ARUP Laboratories: Major academic-affiliated reference laboratory with deep esoteric and molecular testing menus, including infectious disease PCR, women's health, and pharmacogenomics. Highly comparable to MDL on test menu breadth, hospital/physician client base, and emphasis on complex molecular assays.
• Eurofins Viracor BioPharma: Specialty reference laboratory focused on immunology, infectious disease molecular testing, and transplant diagnostics. Comparable to MDL as a niche molecular reference lab with proprietary assays serving physician and institutional clients.
• BioReference Health / An Independent / OPKO Health subsidiary: Full-service clinical reference laboratory with strong women's health, oncology, and infectious disease molecular testing offerings. Closely overlaps with MDL's primary service categories and physician client base.

Broad incumbents

• Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic offering extensive esoteric and specialty testing, including molecular infectious disease and hereditary cancer panels similar to MDL's BRCAcare. Competes for send-out testing from hospitals and specialty practices nationwide.
• Laboratory Corporation of America (LabCorp): National clinical laboratory network with substantial molecular diagnostics and women's health franchises (including post-LabCorp acquisition of Genzyme's women's health business). Competes with MDL for the same physician, hospital, and laboratory client base on PCR-based infectious disease and genetic testing.
• Sonic Healthcare USA: Operates U.S. reference and esoteric labs (e.g., LabOne, American Esoteric Laboratories) with strong women's health and infectious disease molecular testing franchises. Overlaps directly with MDL's core service categories and client profile.
• Quest Diagnostics: One of the two largest U.S. reference laboratories, offering the broadest menu of molecular, genetic, and esoteric diagnostics. Directly comparable to MDL as a competitor for physician and hospital send-out testing volume, though operating at national scale rather than regionally focused.

Regional players

• ACL Laboratories / Advocate Aurora Health reference lab: Mid-sized regional reference laboratory providing molecular infectious disease and women's health testing to hospital systems and physician offices in the U.S. Midwest, competing with MDL's Central Division for similar client workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/GenesisBioJobs
• LinkedInlinkedin.com/company/genesis-biotechnology-group

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Diagnostic Laboratories